CVS Plans to Split Its Healthcare Empire

The news headline is related to CVS and is not expected to have a direct impact on GOOGL; therefore, the direction is uncertain. GOOGL's price has increased by 3.9% in the last 24 hours to 289.03 and is trading above the SMA20 (284.42), but the SMA50 (295.12) remains a resistance. RSI14 is at 51.45, in neutral territory, and although MACD is in negative territory, it is above the signal line, signaling a short-term recovery. Since the news has no direct reflection on GOOGL, the technical outlook suggests a slightly positive but cautious trend in the short term. Nevertheless, unless the SMA50 resistance at 295 is surpassed, the upward movement may remain limited.

CVS stock fell sharply by 11.8% in 24 hours to $80, with RSI at 23.5 indicating oversold territory. MACD is negative below the signal line, and the price is significantly below SMA20 and SMA50; the short-term trend is weak. News of a plan to split the healthcare empire creates uncertainty; volatility may persist until investors assess whether the split will unlock value. While oversold conditions set the stage for rebound buying, directional uncertainty remains until the news flow clarifies. Short-term downward pressure and fluctuations are expected, but the possibility of rebound buying should not be ignored.